- Pettersen, E.F.; Goddard, T.D.; Meng, E.C.; Ferrin, T.E. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25, 1605-1612.
- Zhao, L.; Wuyuan, L. Mirror image proteins. Curr. Opin. Chem. Biol. 2014, 22, 56–61.
- Milton, R.C.; Milton, S.C.; Kent, S.B. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 show reciprocal chiral substrate specificity. Science 1992, 257, 147
- Penteluete, B.L.; Gates, Z.P.; Tereshko, V.; Dashnau, J.L.; Vanderkooi, J.M.; Kossiakoff, A.A.; Kent, S.B.H. X-ray structure of snow flea antifreeze protein determined by racemic X-ray crystallography. J. Am. Chem. Soc. 2008, 130, 9695–9701.
- Venkatraman, J.; Shankaramma, S.C.; Balaram, P. Design of folded peptides. Chem. Rev. 2001, 101, 3131–3152.
- Miller, S. M.; Simon, R. J.; Ng, S.; Zuckermann, R. N.; Kerr, J. M.; Moos, W. H. Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted peptide and peptoid oligomers. Drug Dev. Res. 1995, 35, 20–32.
- Hedstrom, L. Serine protease mechanism and specificity. Chem. Rev. 2002, 102, 4501-4524.
- Schumacher, T. N. M.; Mayr, L. M.; Minor, D. L.; Milhollen, M. A.; Burgess, M. W.; Kim, P. S. Identification of D-peptide ligands through mirror-image phage display. Science 1996, 271, 1854–1857.
- Funke, S.A.; Willbold, D. Mirror image phage display–a method to generate D-peptide ligands for use in diagnostic or therapeutic applications. Mol BioSyst. 2009, 5, 783–786.
- Welch, B.D.; Francis, J.N.; Redman, J.S.; Suparna, P.; Weinstock, M.T.; Reeves, J.D.; Lie, Y.S.; Whitby, F.G.; Eckert, D.M.; Hill, C.P.; Root, M.J.; Kay, M.S. Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance. J. Virol. 2010, 84, 11235–11244.
- Joerger, A.C. and Fersht, A.R. Structural biology of the tumor suppressor p53. Annu. Rev. Biochem. 2008, 77, 557–582.
- Vainer, R.; Cohen, S.; Shahar, A.; Zarivach, R.; Arbely, E. Structural basis for p53 Lys120-acetylation-dependent DNA-binding mode. J. Mol. Biol. 2016, 428, 3013–3025.
- McLure, K.G. and Lee, P.W.K. How p53 binds DNA as a tetramer. EMBO J. 1998, 17, 3342–3350.
- Sanchez, R.; Pantoja-Uceda, D.; Prieto, J.; Diercks, T.; Marcaida, M.J.; Montoya, G.; Campos-Olivas, R.; Bianco, F.J. Solution structure of human growth arrest and DNA damage 45 alpha (Gadd45alpha) and its interactions with proliferating cell nuclear antigen (PCNA) and Aurora A kinase. J. Biol. Chem. 2010, 285, 22196–22201.
- Gulbis, J.M.; Kelman, Z.; Hurwitz, J.; O’Donnell, M.; Kuriyan, J. Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell 1996, 2, 297–306.
- Suzuki, M.; Youle, R.J.; Tjandra, N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000, 103, 645–654.
- Cho, Y.; Forina, S.; Jeffrey, P.D.; Pavletich, N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994, 265, 346–355.
- Tidow, H.; Melero, R.; Mylonas, E.; Freund, S.M.V.; Grossmann, J.G.; Carazo, J.M.; Svergun, D.I.; Valle, M.; Fersht, A.R. Quaternary structures of tumor suppressor p53 and a specific p53-DNA complex. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 12324–12329.
- Wu, X.; Bayle, J.H.; Olson, D.; Levine, A.J. The p53-MDM2 autoregulatory feedback loop. Genes Dev. 1993, 7, 1126–1132.
- Chène, P. Inhibiting the p53-MDM2 interaction: an import target for cancer therapy. Nat. Rev. Cancer 2003, 3, 102–109.
- Honda, R.; Tanaka, H.; Yasuda, H. Oncoprotein MDM2 is a ubiquin ligase E3 for tumor suppressor p53. FEBS Lett. 1998, 420, 25-27.
- Kussie, P.H.; Gorina, S.; Marechal, V.; Elenbaas, B.; Moreau, J.; Levine, A.J.; Pavletich, N.P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1997, 274, 948–953.
- Sanner, M.F.; Olsen, A.J. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 1996, 38, 305–320.
- Freer, S.; Kraut, J.; Robertus, J.; Wright, H.; Xuong, N. Chymotrypsinogen: 2,5-Å crystal structure, comparison with α-chymotrypsin, and implications for zymogen activation. Biochemistry 1970, 9, 1997–2009.
- Bratkovič, T. Progress in phage display: evolution of the technique and its applications. Cell. Mol. Life Sci. 2010, 67, 749–767.
- Liu, M.; Li, C.; Pazgier, M.; Li, C.; Mao, Y.; Lv, Y.; Gu, B.; Wei, G.; Yuan, W.; Zhan, C.; Lu, W.-Y.; Lu, W. D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 14321–14326.
- Liu, M.; Pazgier, M.; Li, C.; Yuan, W.; Li, C.; Lu, W. A left-handed solution to peptide inhibition of the p53-MDM2 interaction. Angew. Chem. Int. Ed. 2010, 49, 3649–3652.
- Zhan, C.; Zhao, L.; Wei, X.; Wu, X.; Chen, X.; Yuan, W.; Lu, W.; Pazgier, M.; Lu, W. An ultrahigh affinity D-peptide antagonist of MDM2. J. Med. Chem. 2012, 55, 6237-6241.
- Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual Molecular Dynamics. J. Mol. Graph. 1996, 33, 27-38.
- The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC.
- Momand, J.; Aspuria, P.J.; Furuta, S. MDM2 and MDMX regulators of p53 activity. Protein Reviews, Vol. 2. Edited by Zambetti, G.P. Springer, U.S. 154–185 (2005).
- Shafdan, M.; Lopez-Pajares, V.; Yuan, Z.M. MDM2 and MDMX: Alone and together in regulation of p53. Transl. Cancer. Res. 2012, 1, 88–89.
Molecular graphics were generated using VMD [28] and PyMOL [29].
All figures reproduced from previously published works were used in accordance with the original publishers’ rights and permissions policies, and written permission to do so was obtained when these policies required it.
A note for references: I mentioned this in the question page, but I think it is a little distracting to have references at the bottom of each webpage. If your goal is to make it accessible, you can still include all the references on this last webpage and then hyperlink each citation to the source link or the references tab.
On the whole, this is an extremely detailed project and I learned so much! I was truly fascinated about the applications of D-peptides. My biggest suggestion would be to make each section a little more user-friendly and readable. There are lots of details discussed in each section and simple figures diagramming pathways or modes of action/inhibition would significantly help ease the presentation of this information. It is clear that you did phenomenal research into the topic, and I think restructuring how it is presented on the webpage will help readability of the project.
This project was amazing! It was such a pleasure to read. I agree with Suraj that having all of your references on one page and just linking to them would be so much easier for the reader.
Going off of Suraj’s comments, having more figures to summarize the information and more summary points would be good. There is so much detail here, but I sometimes wasn’t able to appreciate it because I was so bogged down by the details. Having figures or summaries to allow readers to take a step back and remember what the big picture is would add so much.
Overall, though, well done!
I’m going to digress a little from Suraj here. I think that the references on the bottom of the pages are actually useful. If I were trying to do research based off of the information on this website, I wouldn’t want to constantly be flipping to the reference page everytime I wanted to read more on the source. Have the citations repeated at the bottom of the page would mean I wouldn’t have to do that. Plus, I don’t think it’s that distracting.
As for my other general comments, as I’ve mentioned several times in my comments the description is very detailed and excellent, but hard to read. I don’t think it would be the worst thing in the world for you to edit some of the nuggets of information in order to increase the flow of the page. Additionally, figures help a lot.
Overall, this is a really good project, and I can clearly tell that not only have you done a lot of great research, but you’ve learned a ton about the topic along the way. Keep up the great work!